Company Filing History:
Years Active: 2007
Title: Denis Portnoï: Innovator in Tuberculosis Research
Introduction
Denis Portnoï is a notable inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the area of tuberculosis research. His work focuses on developing innovative solutions for diagnosing and preventing this serious infectious disease.
Latest Patents
Denis Portnoï holds a patent for "Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis." This invention involves recombinant vectors replicated in mycobacteria, which include a set of sequences coding for exported polypeptides. One notable polypeptide, called DP428, corresponds to an exported protein found in mycobacteria. The invention also encompasses methods and kits for detecting the presence of mycobacteria in biological samples, as well as immunogenic or vaccine compositions aimed at preventing and treating infections caused by these bacteria.
Career Highlights
Denis Portnoï is affiliated with the prestigious Institut Pasteur, where he conducts his research. His work has been instrumental in advancing our understanding of tuberculosis and developing effective diagnostic and therapeutic strategies.
Collaborations
He has collaborated with esteemed colleagues, including Brigitte Gicquel and Eng-Mong Lim, to further enhance the impact of his research in the field.
Conclusion
Denis Portnoï's innovative contributions to tuberculosis research highlight the importance of scientific advancements in combating infectious diseases. His patent and ongoing work at the Institut Pasteur continue to pave the way for improved diagnostic and treatment options for tuberculosis.